Search our Database of Scientific Publications and Authors

I’m looking for a

    1861 results match your criteria Canadian Journal of Urology[Journal]

    1 OF 38

    Cryptorchidism: experience and reason.
    Can J Urol 2017 Aug;24(4):8941-8945
    Department of Pediatric Urology, Women & Children's Hospital of Buffalo, Buffalo, New York, USA.
    Introduction: To characterize our contemporary clinical experience with cryptorchidism.

    Materials And Methods: The records of boys referred for cryptorchidism were reviewed from 2001 to 2011. Data regarding the incidence of retractile testes, testicular ascent, surgical approach and outcomes were tabulated. Read More

    How I do it: Balloon tamponade of prostatic fossa following Aquablation.
    Can J Urol 2017 Aug;24(4):8937-8940
    PROCEPT BioRobotics Corporation, Redwood Shores, California, USA.
    Since its first report in the 1870s, control of bleeding after transurethral resection of the prostate (TURP) has remained a concern. Foley's initial report of a urinary catheter involved placement of the balloon into the prostatic fossa following TURP. Removal of prostate tissue with a high-velocity saline stream (Aquablation) is a recently reported alternative to TURP. Read More

    Amyloidosis and acute hemorrhage of the kidney, ureter, and bladder.
    Can J Urol 2017 Aug;24(4):8934-8936
    Department of Urology, Hahnemann University Hospital/Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.
    Gross hematuria is a common occurrence in adults. The differential diagnosis is extensive, including: malignancy, trauma, inflammation of the urinary tract, and stones. While, urinary tract amyloidosis represents only a small percentage of causative gross hematuria, it is concerning because of its superficial resemblance to malignant processes. Read More

    A case of emphysematous cystitis caused by Klebsiella pneumoniae.
    Can J Urol 2017 Aug;24(4):8932-8933
    Department of Urology, Hospital Italiano de Buenos Aires, Argentina.
    Emphysematous cystitis is a rare type of urinary tract infection that is characterized by air pockets within the bladder wall and lumen, which come from gas that is mainly produced by gram-negative bacteria, notably Escherichia coli. This infection is more common in older women with poorly controlled diabetes. An abdominal computerized tomography (CT) scan is the gold standard method to make the diagnosis. Read More

    180W-LBO GreenLight XPS laser vaporization for benign prostatic hyperplasia: our experience with current markers of surgical proficiency for durable and reproducible outcomes.
    Can J Urol 2017 Aug;24(4):8922-8931
    CHUM Section of Urology, Department of Surgery, Université de Montréal, Montreal, Quebec, Canada.
    Introduction: This study aims at analyzing the impact of reaching current markers of proficiency on intra and postoperative clinical outcomes of laser vaporization with 180W GreenLight XPS in the treatment of benign prostatic hyperplasia.

    Materials And Methods: A retrospective analysis was conducted on a prospectively collected database of 328 consecutive patients who underwent photoselective vaporization of the prostate (PVP) using Greenlight XPS performed by a single experienced laser surgeon. A logarithmic model was used to evaluate the case number to attain benchmark criteria for durable treatment. Read More

    Surgical technique for removal of tined lead for InterStim.
    Can J Urol 2017 Aug;24(4):8918-8920
    Department of Urology, University of California, Irvine, California, USA.
    Introduction: We aimed to introduce our technique describing the removal of a chronic implanted tined-lead in patients with a sacral neuromodulator implant.

    Materials And Methods: We performed a retrospective review of patients who had chronic sacral neuromodulator (InterStim) implanted by a single surgeon from 2001 through 2015. This simple surgical technique was developed and successfully performed to remove the leads. Read More

    A decision aid versus shared decision making for prostate cancer screening: results of a randomized, controlled trial.
    Can J Urol 2017 Aug;24(4):8910-8917
    Virginia Mason, Section of Urology and Renal Transplantation, Seattle, Washington, USA.
    Introduction: Shared decision making (SDM) is widely encouraged by both the American Urological Association and Choosing Wisely for prostate cancer screening. Implementation of SDM is challenging secondary to time constraints and competing patient priorities. One strategy to mitigate the difficulties in implementing SDM is to utilize a decision aid (DA). Read More

    Preoperative symptoms predict continence after post-radiation transurethral resection of prostate.
    Can J Urol 2017 Aug;24(4):8903-8909
    MedStar Washington Hospital Center, Washington, District of Columbia, USA.
    Introduction: Lower urinary tract symptoms and retention are known complications of radiation for prostate cancer and traditionally transurethral resection of the prostate (TURP) has been avoided in these patients because of the risk of incontinence. The purpose of this study was to evaluate the incidence and predictors of post-TURP incontinence in previously radiated patients.

    Materials And Methods: One-hundred and eleven patients who underwent brachytherapy or external beam radiotherapy for prostate cancer with subsequent TURP performed between 1992 and 2012 at a single institution were identified. Read More

    Preoperative immunonutrition prior to radical cystectomy: a pilot study.
    Can J Urol 2017 Aug;24(4):8895-8901
    Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
    Introduction: To investigate the use of a high-arginine immunonutrient supplement prior to radical cystectomy for bladder cancer.

    Materials And Methods: We recruited 40 patients to consume a total of four high-arginine immunonutrient shakes per day for 5 days prior to radical cystectomy. The primary outcome measures were safety, tolerability and adherence to the supplementation regimen. Read More

    Clinical use of patient decision-making aids for stone patients.
    Can J Urol 2017 Aug;24(4):8890-8894
    Department of Urology, University of Wisconsin, Madison, Wisconsin, USA.
    Introduction: Patient decision-making aids (PDMAs) help patients make informed healthcare decisions and improve patient satisfaction. The utility of PDMAs for patients considering treatments for urolithiasis has not yet been published. We report our experience using PDMAs developed at our institution in the outpatient clinical setting in patients considering a variety of treatment options for stones. Read More

    Procedural povidone iodine rectal preparation reduces bacteriuria and bacteremia following prostate needle biopsy.
    Can J Urol 2017 Aug;24(4):8883-8889
    Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
    Introduction: To determine if a povidone iodine rectal preparation (PIRP) reduces rates of bacteriuria and bacteremia following transrectal ultrasound guided prostate needle biopsy (TRUS PNB).

    Materials And Methods: Men undergoing TRUS PNB were prospectively enrolled in a study comparing the impact of PIRP versus standard of care (two pills of ciprofloxacin 500 mg). Urine, blood, and rectal cultures were obtained 30 minutes post-procedure with colony forming units (CFUs) determined after 48 hours. Read More

    MRI-targeted biopsy: is systematic biopsy obsolete?
    Can J Urol 2017 Aug;24(4):8876-8882
    Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
    Introduction: Although prostate cancer is the most common non-cutaneous cancer in men, it is traditionally diagnosed with a non-targeted, systematic transrectal ultrasound prostate biopsy (TRUS-Bx). This technique has been demonstrated to both under-detect clinically significant (CS) cancer and over-detect clinically insignificant cancer, and performs poorly in patients with a prior negative biopsy. With recent advances in MRI technology, most prominently the advent of multiparametric MRI, MRI-targeted prostate biopsy (MRI-TB) has been gaining favor as a more accurate alternative to TRUS-Bx. Read More

    Primary amyloidosis of the bladder; a mimicker of bladder cancer.
    Can J Urol 2017 Jun;24(3):8868-8870
    Division of Urology, Department of Surgery, University of Ottawa, The Ottawa Hospital, Ottawa, Ontario, Canada.
    Amyloidosis is a protein folding disorder characterized by the deposition of fibrillar proteins into solid organs or tissues. Primary localized amyloidosis of the bladder is very rare and can mimic bladder cancer in its presentation with hematuria, lower urinary tract symptoms or a mass on imaging. A case of localized amyloidosis of the bladder in a 48-year-old man with painless gross hematuria and evidence of bladder mass on ultrasound is presented. Read More

    Oncocytic adrenocortical carcinoma: a rare adrenal tumor subtype.
    Can J Urol 2017 Jun;24(3):8865-8867
    Department of Urology, Saint John Regional Hospital, Saint John, New Brunswick, Canada.
    Oncocytic tumors arising from the adrenal gland are rare. Oncocytic adrenal neoplasms (OAN) may mimic adrenocortical carcinoma (ACC) at presentation, and can only be definitively diagnosed histologically. Most OANs are benign, and carry a favorable prognosis. Read More

    State of the art: Advanced techniques for prostatic urethral lift for the relief of prostate obstruction under local anesthesia.
    Can J Urol 2017 Jun;24(3):8859-8864
    Eisenhower Medical Center, Rancho Mirage, California, USA.
    Benign prostatic hypertrophy (BPH) affects an estimated 60% of men over the age of 50 and 90% of men over the age of 80. The prostatic urethral lift (PUL) is a safe and effective office-based procedure that is used worldwide for the treatment of BPH in men who are dissatisfied with medications due to side effects or lack of efficacy or don't want to have a transurethral resection of the prostate due to the side effects and invasiveness of the procedure. In 2012 Barkin et al, published the standard technique for the delivery of the Urolift implant. Read More

    Endoscopic placement of double-J ureteric stents in children as a treatment for primary hydronephrosis.
    Can J Urol 2017 Jun;24(3):8853-8858
    Department of Pediatric Surgery, Split University Hospital, Split, Croatia.
    Introduction: The aim of this study was to determine the efficacy and potential complications of double-J ureteric stents in the treatment of primary hydronephrosis in pediatric patients.

    Materials And Methods: A retrospective case-records review of 133 patients (45 girls and 88 boys) treated because of primary hydronephrosis with double-J ureteric stents, in Department of Pediatric Surgery, Split University Hospital, between December 1997 and December 2014, was performed. Success of treatment, results of follow up investigations and complications were recorded. Read More

    Postwash total motile sperm count: should it be included as a standard male infertility work up.
    Can J Urol 2017 Jun;24(3):8847-8852
    Department of Urology, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, Saudi Arabia.
    Introduction: Pregnancy rates after intrauterine insemination (IUI) varies greatly. We aimed to identify pre and post processing semen analysis parameters that may be predictive of successful pregnancy in couples undergoing IUI.

    Materials And Methods: A retrospective study of the records of all couples underwent IUI for a 2 year period at our infertility center. Read More

    Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation.
    Can J Urol 2017 Jun;24(3):8838-8846
    Department of Urology, Faculty of Medicine, Benha University, Egypt.
    Introduction: To compare the safety and efficacy of posterior tibial nerve stimulation (PTNS) versus an intradetrusor injection of botulinum toxin type-A (BTX-A) 100 U in the management of refractory idiopathic overactive bladder (OAB).

    Materials And Methods: We randomized 60 patients with refractory idiopathic OAB to receive an intradetrusor injection of BTX-A 100 U or PTNS. We assessed the patients at baseline, 6 weeks, 3 months, 6 months, and 9 months, and determined their clinical symptoms, overall OAB symptom score, urgency score, quality-of-life score, and urodynamic study parameters. Read More

    Hounsfield Units for nephrolithiasis: predictive power for the clinical urologist.
    Can J Urol 2017 Jun;24(3):8832-8837
    Section of Urology, Department of Surgery University of Chicago, Chicago, Illinois, USA.
    Introduction: We aim to determine the optimal method for measuring Hounsfield Units (HU) of calculi for the clinical urologist.

    Materials And Methods: We present a single institution prospective study from 2014-2015 for 125 consecutive patients. Demographics, baseline characteristics, imaging, and stone analysis were collected. Read More

    A survey of patient preferences regarding medical expulsive therapy following the SUSPEND trial.
    Can J Urol 2017 Jun;24(3):8827-8831
    Department of Urology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
    Introduction: Several recent trials have reported limited benefit for medical expulsive therapy (MET) in terms of stone passage rates, analgesic requirements, or need for intervention. We evaluated patient attitudes regarding MET after explaining these new findings.

    Materials And Methods: Over a 12 week period, an investigator-designed survey was offered to sequential patients during routine appointments in our urologic clinic. Read More

    Comparison of external beam radiotherapy versus permanent seed brachytherapy as monotherapy for intermediate-risk prostate cancer - a single center Canadian experience.
    Can J Urol 2017 Jun;24(3):8822-8826
    Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Québec, Canada.
    Introduction: We tested different classification systems in order to separate intermediate-risk prostate cancers into prognostic groups. We then examined which groups were most suited for either prostate seed brachytherapy (PB) or external beam radiotherapy (EBRT).

    Materials And Methods: We selected patients with D'Amico intermediate-risk prostate cancer who were treated exclusively with either PB or EBRT. Read More

    Surgical flow disruptions during robotic-assisted radical prostatectomy.
    Can J Urol 2017 Jun;24(3):8814-8821
    Division of Urology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
    Introduction: We sought to apply the principles of human factors research to robotic-assisted radical prostatectomy to understand where training and integration challenges lead to suboptimal and inefficient care.

    Materials And Methods: Thirty-four robotic-assisted radical prostatectomy and bilateral pelvic lymph node dissections over a 20 week period were observed for flow disruptions (FD) - deviations from optimal care that can compromise safety or efficiency. Other variables - physician experience, trainee involvement, robot model (S versus Si), age, body mass index (BMI), and American Society of Anesthesiologists (ASA) physical status - were used to stratify the data and understand the effect of context. Read More

    Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study.
    Can J Urol 2017 Jun;24(3):8802-8813
    University of Texas Southwestern Medical Center, Dallas, Texas, USA.
    Introduction: To report the five year results of a prospective, multi-center, randomized, blinded sham control trial of the Prostatic Urethral Lift (PUL) in men with bothersome lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).

    Materials And Methods: At 19 centers in North America and Australia, 206 subjects ≥ 50 years old with International Prostate Symptom Score (IPSS ) > 12, peak flow rate (Qmax) ≤ 12 mL/s, and prostate volume 30 cc-80 cc were randomized 2:1 to the PUL procedure or blinded sham control. In PUL permanent UroLift implants are placed to hold open the lateral lobes of the prostate to reduce urinary obstruction. Read More

    Timing interval from peri-prostatic block to biopsy impacts procedural pain.
    Can J Urol 2017 Jun;24(3):8795-8801
    Department of Urology, Mayo Clinic, Jacksonville, Florida, USA.
    Introduction: To compare visual analog scale (VAS) pain scores between patients with a 2-minute versus 10-minute delay of peri-prostatic lidocaine injection prior to transrectal ultrasound-guided prostate biopsies (TRUS-bx).

    Materials And Methods: Eighty patients who underwent standard 12-core TRUS-bx by a single surgeon were prospectively randomized into four different treatment arms: bibasilar injection with a 2-minute delay, bibasilar injection plus a single apical injection with a 2-minute delay, bibasilar injection with a 10-minute delay, and bibasilar injection plus a single apical injection with a 10-minute delay. Patients were asked to report their level of pain on the VAS (0-10, with 10 indicating unbearable pain) at the following intervals: probe insertion (baseline), after each core, and post-procedure. Read More

    BCG: A throwback from the stone age of vaccines opened the path for bladder cancer immunotherapy.
    Can J Urol 2017 Jun;24(3):8788-8793
    Queen's University, Kingston, Ontario, Canada.
    Introduction: It is 40 years since the initial documentation of the efficacy of bacille Calmette-Guérin (BCG) in the management of non-muscle invasive bladder cancer (NMIBC) and probably an opportune a time as any to retrace the origins of this development and to reflect on the progress that has occurred on the use of immune modifiers in the treatment of NMIBC.

    Materials And Methods: A PubMed search for publications on the history of BCG was conducted, and those related to the development of the vaccine for protection against tuberculosis as well as those published in the last 40 years related to its use for treatment for NMIBC were selected for review. A manual search was also carried out for recent articles on immunotherapy for NMIBC failing to respond to BCG. Read More

    Treating male retention patients with temporary prostatic stent in a large urology group practice.
    Can J Urol 2017 Apr;24(2):8776-8781
    Advanced Urology Institute, Oxford, Florida, USA.
    Men with either chronic or temporary urinary retention symptoms are common patients treated in a urology practice. Both indwelling and intermittent catheterization are widely used to treat this condition. These approaches are associated with significant complications including infection and reduced quality-of-life. Read More

    'Pseudo' pseudoaneurysm following robotic assisted partial nephrectomy.
    Can J Urol 2017 Apr;24(2):8773-8775
    Department of Urology, Mayo Clinic, Jacksonville, Florida, USA.
    A 65-year-old female presented to clinic requesting follow up for a history of right robotic partial nephrectomy done at an outside institution 2 years prior. Initial pathology demonstrated a grade 2/4 3.4 cm clear cell renal cell carcinoma with negative margins. Read More

    Bilateral obstructing ureteric calculi in pregnancy: a rare cause of acute renal failure.
    Can J Urol 2017 Apr;24(2):8770-8772
    Department of Surgery, University of Melbourne, Austin Hospital, Melbourne, Australia.
    Bilateral obstructing ureteric calculi is a rare cause of acute renal failure. Although urolithiasis in later pregnancy is not uncommon, the development of bilateral obstruction secondary to ureteric calculi in the first trimester is rare and poses difficulty to diagnosis and management. Symptoms of diseases and physiological changes associated with pregnancy can obscure diagnosis of urolithiasis and obstructive uropathy. Read More

    Analysis of preoperative antibiotic prophylaxis in stented, distal hypospadias repair.
    Can J Urol 2017 Apr;24(2):8765-8769
    Pediatric Urology Division, Arkansas Children's Hospital, Little Rock, Arkansas, USA.
    Introduction: Surgical site infection [SSI] is a risk for any surgical procedure, including hypospadias repair. Prophylactic antibiotic therapy for patients having surgery is often effective in preventing SSIs, but with increasing rates of antibiotic resistance, this practice has been questioned. The objectives of this study are 1) to assess the incidence of SSIs in patients following stented, distal hypospadias repair and 2) to observe for any potential difference in the incidence of SSIs for patients with and without preoperative antibiotic utilization in this setting. Read More

    Adverse pathologic characteristics in the small renal mass: implications for active surveillance.
    Can J Urol 2017 Apr;24(2):8759-8764
    Department of Urology, Yale School of Medicine, New Haven, Connecticut, USA.
    Introduction: Evidence has demonstrated that tumor size is related to adverse oncologic outcomes in small renal tumors (≤ 4 cm). We evaluated the association of adverse pathologic features (APF) with tumor size and survival in patients with a small renal mass (SRM).

    Materials And Methods: We retrospectively reviewed the pathologic characteristics of 380 surgically resected SRMs from a single institution. Read More

    Upper pole urologist-obtained percutaneous renal access for PCNL is safe and efficacious.
    Can J Urol 2017 Apr;24(2):8754-8758
    Department of Urology, Emory University School of Medicine, Atlanta, Georgia, USA.
    Introduction: Interventional radiologist may be hesitant to obtain upper pole access for percutaneous nephrolithotomy (PCNL) due to a higher complication rate. Renal access gained by urologists may achieve higher stone-free rates with similar complication rates. We evaluate our institution's contemporary results of percutaneous renal access in the upper pole for nephrolithotomy by urologists, which we believe both safe and efficacious. Read More

    Supracostal punctures in supine percutaneous nephrolithotomy are safe.
    Can J Urol 2017 Apr;24(2):8749-8753
    Division of Urology, Department of Surgery, University of Sāo Paulo Medical School, Sāo Paulo, Brazil.
    Introduction: The feasibility and safety of supracostal punctures in supine percutaneous nephrolithotomy (PCNL) are still controversial. In this study we aim to compare success and complication rates from prone and supine PCNL with at least one supracostal puncture.

    Material And Methods: We reviewed our electronic database for all supracostal PCNLs performed in our institution from February 2008 to September 2013. Read More

    Comparative analysis of anticipated pain versus experienced pain in patients undergoing office vasectomy.
    Can J Urol 2017 Apr;24(2):8744-8748
    Department of Urology, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, USA.
    Introduction: Advances in vasectomy technique have minimized patient discomfort; however fear of pain remains a primary concern. The objective is to determine how the anticipation of pain associated with vasectomy compares with patient's actual intraoperative experienced pain levels.

    Materials And Methods: A cohort of patients undergoing clinic vasectomy was analyzed. Read More

    Robotic repair of vesicovaginal fistulas using fibrin sealant.
    Can J Urol 2017 Apr;24(2):8740-8743
    Department of Surgery, Division of Urology, Baylor Scott & White Health/The Texas A&M Health Science Center College of Medicine, Temple, Texas, USA.
    Introduction: Although infrequent, when encountered vesicovaginal fistulas (VVF) are a difficult condition for both patients and physicians alike. After the first robotic repair was described in 2005, this has been an increasingly common treatment modality. At our institution between 2009 and 2014, eleven of these patients were evaluated and treated with robotic repair. Read More

    Prostate cancer screening practices amongst physicians in the North Simcoe Muskoka Local Health Integration Network.
    Can J Urol 2017 Apr;24(2):8734-8739
    Barrie Urology Group, Barrie, Ontario, Canada.
    Introduction: The prostate-specific antigen (PSA) screening test is controversial and can result in both over-diagnosis and over-treatment. Recently, the Canadian Task Force on Preventive Health Care (CTFPHC) has recommended against routine screening for prostate cancer. We sought to determine how the CTFPHC has impacted the practice patterns among family physicians in the North Simcoe Muskoka (NSM) Local Health Integration Network (LHIN). Read More

    Robotic prostatectomy versus brachytherapy for the treatment of low risk prostate cancer.
    Can J Urol 2017 Apr;24(2):8728-8733
    Department of Urology, San Paolo Hospital, Savona, Italy.
    Introduction: To compare oncological and functional results of robot-assisted radical prostatectomy (RARP) and brachytherapy (BT) with a single-center prospective randomized study.

    Materials And Methods: From January 2012 to January 2014, 165 patients with low risk prostate cancer, prostate volume ≤ 50 g, normal urinary (IPSS ≤ 7 and mean flow rate ≥ 15 mL/sec) and erectile functions (IIEF-5 > 17) were enrolled and randomly assigned to the RARP or BT group. Our end points included the comparison of biochemical recurrence-free survival rates, urinary function (IPSS and EPIC scores) and potency rates (IIEF-5 score) at different time points during the first 2 years after surgery between the two groups. Read More

    A validation study of new decision algorithms for interpretation of cancer significance on prostate systematic biopsy.
    Can J Urol 2017 Apr;24(2):8721-8727
    Center for Clinical Effectiveness, Office of the Chief Quality Officer, Baylor Scott and White Health, Dallas, Texas, USA.
    Introduction: To test with actual data a new decision algorithm derived by probability modeling of the number of positive cores, for deciding insignificant versus significant prostate cancer, based on prostate volume, Gleason score, tumor length on biopsy cores, and number of positive cores.

    Materials And Methods: A dataset of 59 cancer-involved autopsied prostate glands from patients aged 42 to 92 years with prostate volumes of 22 cc to 95 cc was used. An 18 core-systematic biopsy was performed on the first 47 patients, and saturation biopsy protocol of 36 cores was performed on the remainder. Read More

    Prostate cancer detection following diagnosis of atypical small acinar proliferation.
    Can J Urol 2017 Apr;24(2):8714-8720
    Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.
    Introduction: To report the incidence and characteristics of cancer following a diagnosis of atypical small acinar proliferation (ASAP) and comment on current clinical practice recommendations.

    Materials And Methods: We reviewed patients that underwent prostate biopsy between 2008 and 2013 at a single institution. Men with ASAP without previous cancer were included. Read More

    Association between natural killer cell activity and prostate cancer: a pilot study.
    Can J Urol 2017 Apr;24(2):8708-8713
    Department of Urology, University of Toronto, Humber River Hospital, Toronto, Ontario, Canada.
    Introduction: Natural killer (NK) cells play a significant role in tumor cell immunosurveillance. The association between the activity of NK cells and prostate cancer has previously been demonstrated using conventional research-based tests.

    Materials And Methods: The aim of the present pilot study was to study the association between NK cell activity (NKA) and prostate cancer using a simple blood test. Read More

    Quantification of risk factors in 500 patients with postoperative urinary retention.
    Can J Urol 2017 Apr;24(2):8705-8707
    Department of Urology, Rush University Medical Center, Chicago, Illinois, USA.
    Introduction: An Institutional Quality and Safety Initiative to reduce postoperative urinary retention (POUR) and improve patient safety indicators (PSIs) was undertaken after a nurse driven protocol for catheter removal lead to an increase in POUR. The aim of this study was to identify the number of risk factors present in patients with POUR while examining the prevalence of those risk factors individually.

    Materials And Methods: A retrospective review of our institution's surgical database was performed to identify 500 consecutive cases of POUR between July 1, 2013 and July 1, 2014. Read More

    What is the current role of partial nephrectomy for T2 tumors?
    Can J Urol 2017 Apr;24(2):8698-8704
    Department of Urology, University of Miami Miller School of Medicine, Miami, Florida, USA.
    Introduction: To review oncological and functional outcomes for partial nephrectomy in the setting of T2 tumors.

    Materials And Methods: We performed a comprehensive literature review on partial nephrectomy for T2 tumors, focusing on major primary series reporting oncological and functional outcomes, as well as complication rates in the last 10 years.

    Results: Recent series have reported comparable oncological outcomes between partial nephrectomy and radical nephrectomy for ≥ T2 tumors. Read More

    1 OF 38